(Q37869934)

24 August 2017

1 reference

title

MicroRNA profiling in cancer (English)

1 reference

24 August 2017

1 reference

1 reference

2

George A Calin

1 reference

24 August 2017

Reinhold Munker

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

121

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

141-158

1 reference

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

DNA microarrays are predictive of cancer prognosis: a re-evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Expression profiling of microRNA using oligo DNA arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Intra-platform repeatability and inter-platform comparability of microRNA microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Cross-platform analysis of global microRNA expression technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiling in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Karyotype-specific microRNA signature in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

The biology of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiling in lymphoma diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiling in acute myeloid leukaemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

The impact of gene profiling in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene-expression-based prognostic assays for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiling of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

microRNA-205 regulates HER3 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MYC-microRNA-9-metastasis connection in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Molecular profiling and risk stratification of adenocarcinoma of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Molecular characterization of ovarian cancer by gene-expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNAs in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Signatures of microRNAs and selected microRNA target genes in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

The microRNA profile of prostate carcinoma obtained by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA deregulation in human thyroid papillary carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du M

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110005

21 January 2018

Identifiers

DOI

10.1042/CS20110005

1 reference

24 August 2017

1 reference